IL1A and depressive symptom measurement: This oxidative stress and increased depression lead to demyelination and cerebral atrophy, accompanied by elevated concentrations of inflammatory mediators such as tumor necrosis factor (TNFα) and specifically interleukin IL-6, along with IL-1α and IL-1β, in the serum and CSF (47).